<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="psp412510-fig-0001" orientation="portrait" position="float">
 <label>Figure 1</label>
 <caption>
  <p>Top: Pharmacokinetic model for favipiravir in non‐human primates; bottom: predicted drug concentrations at D7 for three levels of dosing regimens and comparisons with drug half‐maximal effective concentration for various emerging viruses. CCHFV, Crimea Congo haemorrhagic fever virus; EBOV, Ebola virus; JUNV, Junin virus; LAV, Lassa fever virus; MARV, Marburg virus; RVFV, Rift valley fever virus; YFV, Yellow fever virus. Reproduced from ref. 
   <xref rid="psp412510-bib-0008" ref-type="ref">8</xref>.
  </p>
 </caption>
 <graphic id="nlm-graphic-1" xlink:href="PSP4-9-258-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
